1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Strategies for Development of Coronavirus Vaccines That Induce Broadly Reactive Neutralizing Antibodies"}],["$","meta","1",{"name":"description","content":"COVID-19 Lecture Series \n

\nDr. Haynes is the Frederic M. Hanes Distinguished Professor of Medicine and director of the Human Vaccine Institute at Duke University School of Medicine in Durham, North Carolina. He is internationally recognized for his work in T-cell immunology, retrovirology and HIV vaccine development.\n

\nDr. Haynes will relay his lab's latest research on the isolation of coronavirus cross-reactive antibodies and the design of pan-coronavirus vaccines that currently show promise in inducing cross-reactive antibodies and neutralizing pre-emergent animal coronaviruses and SARS-CoV-2 variants of concern. He will discuss coronavirus spike protein neutralizing epitopes as well as mRNA-lipid nanoparticle and protein nanoparticle platforms for vaccine development.\n

\nFor more information go to https://www.niaid.nih.gov/research/covid-19-sig"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Strategies for Development of Coronavirus Vaccines That Induce Broadly Reactive Neutralizing Antibodies"}],["$","meta","4",{"property":"og:description","content":"COVID-19 Lecture Series \n

\nDr. Haynes is the Frederic M. Hanes Distinguished Professor of Medicine and director of the Human Vaccine Institute at Duke University School of Medicine in Durham, North Carolina. He is internationally recognized for his work in T-cell immunology, retrovirology and HIV vaccine development.\n

\nDr. Haynes will relay his lab's latest research on the isolation of coronavirus cross-reactive antibodies and the design of pan-coronavirus vaccines that currently show promise in inducing cross-reactive antibodies and neutralizing pre-emergent animal coronaviruses and SARS-CoV-2 variants of concern. He will discuss coronavirus spike protein neutralizing epitopes as well as mRNA-lipid nanoparticle and protein nanoparticle platforms for vaccine development.\n

\nFor more information go to https://www.niaid.nih.gov/research/covid-19-sig"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/c2e6a7db-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/5210fead-b8a1-4d14-b367-224dbe8c070b.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Strategies for Development of Coronavirus Vaccines That Induce Broadly Reactive Neutralizing Antibodies"}],["$","meta","11",{"name":"twitter:description","content":"COVID-19 Lecture Series \n

\nDr. Haynes is the Frederic M. Hanes Distinguished Professor of Medicine and director of the Human Vaccine Institute at Duke University School of Medicine in Durham, North Carolina. He is internationally recognized for his work in T-cell immunology, retrovirology and HIV vaccine development.\n

\nDr. Haynes will relay his lab's latest research on the isolation of coronavirus cross-reactive antibodies and the design of pan-coronavirus vaccines that currently show promise in inducing cross-reactive antibodies and neutralizing pre-emergent animal coronaviruses and SARS-CoV-2 variants of concern. He will discuss coronavirus spike protein neutralizing epitopes as well as mRNA-lipid nanoparticle and protein nanoparticle platforms for vaccine development.\n

\nFor more information go to https://www.niaid.nih.gov/research/covid-19-sig"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}